A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines

International Journal of Oncology

Volumn 37, Issue 2, 2010, Pages 367-376

  Culpin, Rachel E ^a   Proctor, Stephen J ^a   Angus, Brian ^b   Crosier, Stephen ^b   Anderson, John J ^a   Mainou Fowler, Tryfonia ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Diffuse large B cell lymphoma; microRNA expression profiling; microRNA microarray

Indexed keywords

MICRORNA; CD19 ANTIGEN;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CANCER CELL CULTURE; CANCER PATIENT; CONTROLLED STUDY; DOWN REGULATION; FOLLICULAR LYMPHOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GERMINAL CENTER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MEDICAL DECISION MAKING; MICROARRAY ANALYSIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VALIDATION PROCESS; CLUSTER ANALYSIS; DIFFERENTIAL DIAGNOSIS; DNA MICROARRAY; GENETICS; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; TUMOR CELL LINE; VALIDATION STUDY;

ANTIGENS, CD19; B-LYMPHOCYTES; CELL LINE, TUMOR; CLUSTER ANALYSIS; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION PROFILING; GERMINAL CENTER; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOMA, LARGE B-CELL, DIFFUSE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 77954146007     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000685     Document Type: Article

References (53)

1. A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma. The non-Hodgkin's lymphoma classification project. Blood 89: 3909-3918, 1997. (Pubitemid 27220933)
2. Horning SJ and Rosenberg SA: The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 311: 1471-1475, 1984.
3. Acker B, Hoppe RT, Colby TV, Cox RS, Kaplan HS and Rosenberg SA: Histologic conversion in the non-Hodgkin's lymphomas. J Clin Oncol 1: 11-16, 1983.
4. Mauch PM, Armitage JO, Coiffier B, Dalla-Favera R and Harris NL: Non-Hodgkin's lymphomas. Lippincott Williams & Wilkins, Philadelphia, PA, USA, 2004.
5. Lossos IS and Morgensztern D: Prognostic biomarkers in diffuse large B-cell lymphoma. J Clin Oncol 24: 995-1007, 2006. (Pubitemid 46638855)
6. Alizadeh AA, Eisen MB, Davis RE, et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511, 2000.
7. Rosenwald A, Wright G, Chan WC, et al: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346: 1937-1947, 2002.
8. Hans CP, Weisenburger DD, Greiner TC, et al: Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103: 275-282, 2004.
9. Muris JJF, Meijer CJLM, Vos W, et al: Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma. J Pathol 208: 714-723, 2006.
10. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE and Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811, 1998.
11. Montgomery MK, Xu S and Fire A: RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc Natl Acad Sci USA 95: 15502-15507, 1998.
12. Pillai RS, Bhattacharyya SN and Filipowicz W: Repression of protein synthesis by miRNAs: How many mechanisms? Trends Cell Biol 17: 118-126, 2007.
13. Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complimentarity to lin-14. Cell 75: 843-854, 1993.
14. Mendell JT: Miriad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222, 2008. (Pubitemid 351508308)
15. Vasudevan S, Tong Y and Steitz JA: Switching from repression to activation: MicroRNAs can up-regulate translation. Science 318: 1931-1934, 2007.
16. Calin GA, Sevignani C, Dumitru CD, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004, 2004.
17. Sevignani C, Calin GA, Nnadi SC, et al: MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc Natl Acad Sci USA 104: 8017-8022, 2007.
18. Calin GA, Dumitru CD, Shimizu M, et al: Frequent deletions and down-regulation of microRNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529, 2002.
19. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
20. Malumbres R, Sarosiek KA, Cubedo E, et al: Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 113: 3754-3764, 2009.
21. Lawrie CH, Soneji S, Marafioti T, et al: MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer 121: 1156-1161, 2007.
22. Roehle A, Hoefig KP, Dirk R, et al: MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br J Haematol 142: 732-744, 2008.
23. Lawrie CH, Chi J, Taylor S, et al: Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. J Cell Mol Med 13: 1248-1260, 2009.
24. Anderson JJ, Fordham S, Overman L, et al: Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics. Int J Oncol 35: 961-971, 2009.
25. Tellmann G: The E-method: A highly accurate technique for gene-expression analysis. Nat Met 3: i-ii, 2006.
26. Mourelatos Z, Dostie J, Paushkin S, et al: MiRNPs: A novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev 16: 720-728, 2002.
27. He L, Thomson JM, Hemann MT, et al: A microRNA polycistron as a potential human oncogene. Nature 435: 828-833, 2005.
28. Volinia S, Calin GA, Liu C-G, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006.
29. Landais S, Landry S, Legault P and Rassart E: Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 67: 5699-5707, 2007. (Pubitemid 46985002)
30. Lum AM, Wang BB, Li L, Channa N, Bartha G and Wabl M: Retroviral activation of the miR-106A microRNA cistron in T lymphoma. Retrovirology 4: 5, 2007. (Pubitemid 46243461)
31. Calin GA, Ferracin M, Cimmino A, et al: A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801, 2005.
32. Fabbri M, Garzon R, Cimmino A, et al: MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 104: 15805-15810, 2007.
33. Gebeshuber CA, Zatloukal K and Martinez J: Mir-29A suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 10: 400-405, 2009.
34. Afanasyeva EA, Hotz-Wagenblatt A, Glatting K-H and Westermann F: New miRNAs cloned from neuroblastoma. BMC Genomics 9: 52, 2008.
35. Morin RD, O'Connor MD, Griffith M, et al: Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res 18: 610-621, 2008.
36. Tang X, Gal J, Zhuang X, Wang W, Zhu H and Tang G: A simple array platform for microRNA analysis and its application in mouse tissues. RNA 13: 1803-1822, 2007.
37. Betel D, Wilson M, Gabow A, Marks DS and Sander C: The microRNA.org resource: Targets and expression. Nucleic Acids Res 36: D149-D153, 2008.
38. Kota J, Chivukula RR, O'Donnell KA, et al: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137: 1005-1017, 2009.
39. Sander S, Bullinger L, Klapproth K, et al: MYC stimulates EZH2 expression by repression of its negative regulator miR-26A. Blood 112: 4202-4212, 2008.
40. Akao Y, Nakagawa Y and Naoe T: Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29: 903-906, 2006.
41. Takamizawa J, Konishi H, Yanagisawa K, et al: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756, 2004.
42. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006.
43. Johnson SM, Grosshans H, Shingara J, et al: Ras is regulated by the let-7 microRNA family. Cell 120: 635-647, 2005.
44. Li C, Kim S-W, Rai D, et al: Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma. Blood 113: 6681-6690, 2009.
45. Kutay H, Bai S, Datta J, et al: Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99: 671-678, 2006.
46. Pal S, Baiocchi RA, Byrd JC, et al: Low levels of miR-92B/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma. EMBO J 26: 3558-3569, 2007.
47. Visone R, Pallante P, Vecchione A, et al: Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26: 7590-7595, 2007.
48. Xiao C, Calado DP, Galler G, et al: MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159, 2007.
49. Zhang J, Jima DD, Jacobs C, et al: Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood 113: 4586-4594, 2009.
50. Tsuchiya Y, Nakajima M, Takagi S, Taniya T and Yokoi T: MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res 66: 9090-9098, 2006.
51. Gottardo F, Liu CG, Ferracin M, et al: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392, 2007.
52. Tong AW and Nemunaitis J: Modulation of miRNA activity in human cancer: A new paradigm for cancer gene therapy? Cancer Gene Ther 15: 341-355, 2008.
53. Xia H, Qi Y, Ng SS, et al: MicroRNA-15B regulates cell cycle progression by targeting cyclins in glioma cells. Biochem Biophys Res Commun 380: 205-210, 2009.